Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Virological Methods|October 1, 1990
Serum levels and catabolism of 3'-azido-3'-deoxythymidine in vivo measured using a specific radioimmunoassayS Cox, U Rudén, K Nagy, et al.AIDS Research and Human Retroviruses|February 1, 1994
HIV antigen-reactive T cells detected by antigen-induced interferon gamma secretionF Lolli, L B Chen, V A Sundqvist, et al.Journal of Medical Virology|April 1, 1992
HIV-1 reverse transcriptase inhibiting antibody titer in serum: relation to disease progression and to core-antibody levelsM Neumüller, A Karlsson, J Lennerstrand, et al.AIDS (London, England)|May 11, 1991
Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study GroupD C Montefiori, L B Lefkowitz, R E Keller, et al.Neurology|August 23, 2000
Phenotype-genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5)V Holmberg, L Lauronen, T Autti, et al.Advanced Healthcare Materials|April 5, 2014
Hybrid nanotopographical surfaces obtained by biomimetic mineralization of statherin-inspired elastin-like recombinamersYuping Li, Xi Chen, Artur J Ribeiro, et al.Journal of Human Virology|April 25, 2000
Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDSM Jansson, E Backström, A Björndal, et al.AIDS (London, England)|May 1, 1993
HIV infection leads to differential expression of T-cell receptor V beta genes in CD4+ and CD8+ T cellsV L Hodara, M Jeddi-Tehrani, J Grunewald, et al.Journal of Medical Virology|May 1, 1991
HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies, HIV antigenemia and clinical variablesM Neumüller, A Karlsson, J Lennerstrand, et al.Journal of Acquired Immune Deficiency Syndromes|September 1, 1994
Immunological and virological interactions in patients receiving passive immunotherapy with HIV-1 neutralizing monoclonal antibodiesJ Hinkula, G Bratt, G Gilljam, et al.Pageof 3